B. Riley Maintains Buy on OptimizeRx, Lowers Price Target to $21

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $26 to $21.

Benzinga · 11/06/2019 14:27

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $26 to $21.